Meridian Bioscience
VIVO
#4868
Rank
ยฃ1.17 B
Marketcap
ยฃ26.75
Share price
0.00%
Change (1 day)
23.74%
Change (1 year)

Revenue for Meridian Bioscience (VIVO)

Revenue in 2022 (TTM): ยฃ0.26 Billion

According to Meridian Bioscience's latest financial reports the company's current revenue (TTM ) is ยฃ0.26 Billion. In 2021 the company made a revenue of ยฃ0.23 Billion an increase over the revenue in the year 2020 that were of ยฃ0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Meridian Bioscience from 1996 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) ยฃ0.26 B14.07%
2021 ยฃ0.23 B5.76%
2020 ยฃ0.21 B46.13%
2019 ยฃ0.15 B-10.39%
2018 ยฃ0.16 B9.84%
2017 ยฃ0.15 B-3.8%
2016 ยฃ0.15 B21.19%
2015 ยฃ0.13 B6.11%
2014 ยฃ0.12 B8.16%
2013 ยฃ0.11 B3.2%
2012 ยฃ0.11 B5.56%
2011 ยฃ0.10 B17.28%
2010 ยฃ89.26 M-7.66%
2009 ยฃ96.67 M1.14%
2008 ยฃ95.58 M48.24%
2007 ยฃ64.47 M12.54%
2006 ยฃ57.29 M-0.23%
2005 ยฃ57.42 M37.33%
2004 ยฃ41.81 M10.13%
2003 ยฃ37.97 M-1.24%
2002 ยฃ38.45 M1.68%
2001 ยฃ37.81 M-2.73%
2000 ยฃ38.87 M10.2%
1999 ยฃ35.27 M61.15%
1998 ยฃ21.89 M-0.11%
1997 ยฃ21.91 M18.75%
1996 ยฃ18.45 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ2.21 B 746.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ33.35 B 12,623.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ15.88 B 5,959.13%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.17 B 1,110.23%๐Ÿ‡บ๐Ÿ‡ธ USA